Heart drug trial pulled before it even started
Symptom relief
Terminated
This was a planned Phase 2 study to test whether the drug IMB-1018972 could safely help people with refractory angina—chest pain that doesn't improve with standard treatments. The study aimed to measure exercise capacity, angina symptoms, and activity levels. However, the trial w…
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC